Kontigo Care: Mixed short-term outlook - Redeye - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Aktieanalys

Kontigo Care: Mixed short-term outlook - Redeye

{newsItem.title}

Redeye reiterates its valuation following the Q1 2024 report. We are encouraged by the all-time high net sales, although we recognise the challenges expected for growth in 2024 due to decreased municipal budgets in Sweden. Nevertheless, we maintain optimism regarding the newly launched Previct Drug, which has already gained significant attention in both Sweden and internationally.

Länk till analysen i sin helhet: https://www.redeye.se/research/1004326/kontigo-care-mixed-short-term-outlook?utm_source=finwire&utm_medium=RSS

Nyheter om Kontigo Care

Läses av andra just nu

Om aktien Kontigo Care

Senaste nytt